Lupin Limited (NSE:LUPIN)
India
· Delayed Price · Currency is INR 2,019.60
-84.50 (-4.02%)
Apr 25, 2025, 3:29 PM IST
Lupin Revenue
Lupin had revenue of 57.68B INR in the quarter ending December 31, 2024, with 10.97% growth. This brings the company's revenue in the last twelve months to 220.02B, up 12.94% year-over-year. In the fiscal year ending March 31, 2024, Lupin had annual revenue of 200.11B with 20.25% growth.
Revenue (ttm)
220.02B
Revenue Growth
+12.94%
P/S Ratio
4.19
Revenue / Employee
11.45M
Employees
19,210
Market Cap
921.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 200.11B | 33.69B | 20.25% |
| Mar 31, 2023 | 166.42B | 2.36B | 1.44% |
| Mar 31, 2022 | 164.05B | 12.43B | 8.19% |
| Mar 31, 2021 | 151.63B | -2.12B | -1.38% |
| Mar 31, 2020 | 153.75B | 7.10B | 4.84% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Lupin News
- 3 days ago - Lupin receives U.S. FDA approval for Tolvaptan tablets with 180-day exclusivity - Business Upturn
- 10 days ago - Lupin receives EIR from US FDA for its injectable manufacturing facility in Nagpur - Business Upturn
- 11 days ago - Lupin shares tumble nearly 3% after US court setback in Myrbetriq patent case - Business Upturn
- 21 days ago - Lupin: Business Model, Q3 FY25 Earnings, Promoter Details, and Shareholding Pattern - Business Upturn
- 23 days ago - Lupin shares fall over 6% today as Trump reportedly hints at possible pharma tariffs - Business Upturn
- 24 days ago - Lupin shares jump 6% as U.S. spares pharma exports from 26% tariff - Business Upturn
- 5 weeks ago - Lupin Digital Health launches post-procedure home care guide in collaboration with American College of Cardiology - Business Upturn
- 5 weeks ago - Lupin receives U.S. FDA approval for 10 mg Amifampridine Tablets - Business Upturn